Cargando…
Susceptibility breakpoint for Danofloxacin against swine Escherichia coli
BACKGROUND: Improper use of antimicrobials results in poor treatment and severe bacterial resistance. Breakpoints are routinely used in the clinical laboratory setting to guide clinical decision making. Therefore, the objective of this study was to establish antimicrobial susceptibility breakpoints...
Autores principales: | Yang, Yuqi, Zhang, Yixin, Li, Jiarui, Cheng, Ping, Xiao, Tianshi, Muhammad, Ishfaq, Yu, Hongxiao, Liu, Ruimeng, Zhang, Xiuying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360659/ https://www.ncbi.nlm.nih.gov/pubmed/30717803 http://dx.doi.org/10.1186/s12917-019-1783-2 |
Ejemplares similares
-
Pharmacokinetics and pharmacodynamics integration of danofloxacin against Eschrichia coli in piglet ileum ultrafiltration probe model
por: Yang, Yuqi, et al.
Publicado: (2021) -
Wild-type cutoff for Apramycin against Escherichia coli
por: Yang, Yuqi, et al.
Publicado: (2020) -
Prevalence and molecular epidemiology characteristics of carbapenem-resistant Escherichia coli in Heilongjiang Province, China
por: Cheng, Ping, et al.
Publicado: (2019) -
Exploration of Clinical Breakpoint of Danofloxacin for Glaesserella parasuis in Plasma and in PELF
por: Xu, Zihui, et al.
Publicado: (2021) -
Prevalence and Characteristic of Swine-Origin mcr-1-Positive Escherichia coli in Northeastern China
por: Cheng, Ping, et al.
Publicado: (2021)